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Introduction: Tuberculosis continues to be a major health problem in the world with an incidence of 
more than 10 million cases in 2015. There are factors that change the risk of developing the disease 
after infection, as well as the presentation of the disease.
Objective: To determine the main comorbidities and demographic, clinical and microbiological 
characteristics of tuberculosis adult patients in Argentina from a gender and age perspective. 
Materials and methods: We conducted a cross-sectional study in urban referral hospitals for patients 
with tuberculosis. We included tuberculosis patients of 15 years or more of age who were hospitalized 
or treated in outpatient clinics with bacteriologically confirmed pulmonary or extrapulmonary forms 
of the disease, as well as those who, although not bacteriologically confirmed, had clinical and 
radiological characteristics consistent with tuberculosis. The study period was from August 1st, 2015 
to August 31st, 2016.
Results: We included 378 patients. The median age was 37 years. Male gender was associated with 
extrapulmonary tuberculosis, hospitalization, smoking, drug addiction and alcoholism. Tuberculosis 
and aids (22.6%) was related to drug use, admission into hospital, extrapulmonary tuberculosis, non-
addiction to tobacco, non-pathological radiology, absence of cavitation, and negative sputum smear 
microscopy. Patients less than 40 years of age had a higher rate of drug addiction and low weight, 
while those aged 40 or over had a higher proportion of diabetes, alcoholism and chronic obstructive 
pulmonary disease (COPD).
Conclusions: This study will help recognize tuberculosis patients’ characteristics and comorbidities 
influencing the development and evolution of the disease from an age and gender perspective to 
enable the development of social and community-based strategies.
Key words: Tuberculosis; comorbidity; gender identity; age groups; acquired immunodeficiency 
syndrome; risk factors; Argentina.
doi: https://doi.org/10.7705/biomedica.v38i0.3904 
Tuberculosis y comorbilidades en áreas urbanas de Argentina. Una perspectiva de edad y sexo
Introducción. La tuberculosis continúa siendo un importante problema de salud en el mundo, con 
una incidencia de más de 10 millones de casos en el 2015. Hay factores que modifican el riesgo de 
desarrollar la enfermedad luego de contraer la infección, así como su forma de presentación.
Objetivo. Determinar las principales comorbilidades y características demográficas, clínicas y 
microbiológicas de pacientes adultos con tuberculosis en Argentina, mediante un análisis desde la 
perspectiva de sexo y edad.
Materiales y métodos. Se llevó a cabo un estudio transversal en hospitales de referencia para 
pacientes de áreas urbanas con tuberculosis. Se incluyeron pacientes de 15 años o más con 
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tuberculosis pulmonar o extrapulmonar, confirmada bacteriológicamente y en tratamiento hospitalario 
o ambulatorio, y también, pacientes sin confirmación bacteriológica, pero con características clínicas 
y radiológicas indicativas de tuberculosis. El período de estudio fue del 1º de agosto de 2015 al 31 de 
agosto de 2016. 
Resultados. Se incluyeron 378 pacientes. La mediana de edad fue de 37 años. El sexo masculino 
estuvo asociado con tuberculosis extrapulmonar, hospitalización, tabaquismo, adicción a drogas 
y alcoholismo. Los menores de 40 años presentaron adicción a drogas y bajo peso con mayor 
frecuencia, en tanto que los de 40 años o más presentaron, en mayor proporción, diabetes, alcoholismo 
y enfermedad pulmonar obstructiva crónica (EPOC). Se observaron más casos de sida en el sexo 
masculino, y en edades de 40 años y más.
Conclusiones. Este trabajo permitió conocer las características y las comorbilidades de enfermos de 
tuberculosis, que influyen en el desarrollo y la evolución de la enfermedad, desde una perspectiva de edad 
y sexo, con el objetivo de facilitar enfoques de manejo que incorporan aspectos sociales y comunitarios. 
Palabras clave: tuberculosis; comorbilidad; identidad de género; grupos de edad; síndrome de 
inmunodeficiencia adquirida; factores de riesgo; Argentina.
doi: https://doi.org/10.7705/biomedica.v38i0.3904 
In 2015, an estimate of 10.4 million tuberculosis (TB) 
incident cases occurred on a global scale, 142 per 
100,000 inhabitants; 62% were male, 90% were 
adult and 11% were HIV-positive. In the National 
TB Programs (NTP, 6.1 million new TB cases were 
reported, with the extrapulmonary form accounting 
for 15%; 57% of pulmonary TB (PTB) new and 
relapse cases were bacteriologically confirmed (1).
In Argentina, 10,713 TB cases were reported to 
the NTP in 2015 (24.8 per 100,000 inhabitants); 
new cases and relapses accounted for 91.1%, the 
highest notification rate being observed between 20 
and 24-year-old patients, with 85.5% of pulmonary 
localization, 70.0% with bacteriological confirma-
tion, sputum smear microscopy, SSM, or culture 
and 63.8% with positive SSM (SSM +). Among 
extrapulmonary localizations, the pleural was the 
most frequent, followed by the lymph node and 
meningeal localizations. Coverage of HIV testing in 
patients with TB was 19.8%, of whom 33.4% were 
positive; positivity dropped to 6.5% when the total 
number of cases was considered (2).
The risk of developing TB after contracting infection 
is variable. Some risk factors are known to facilitate 
the development of the disease and to provoke 
a greater or lesser degree of immunodeficiency, 
increasing up to 1,000 times the odds of suffering 
from TB as opposed to people without such risk 
factors (3).
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Common immunocompromised conditions include 
HIV/AIDS, advanced age, cancer, immunosuppres-
sive therapies, diabetes mellitus, renal diseases 
requiring dialysis, malnutrition and liver cirrhosis (4).
HIV infection has been the most important risk factor 
for developing TB in countries with a high burden 
of the disease. However, epidemiological studies 
have highlighted the relevance of other factors in 
perpetuating epidemic TB, including smoking and 
diabetes mellitus (5).
Risk factors may also change PTB presentation, 
including age, diabetes mellitus, AIDS, chronic 
kidney disease, and malnutrition. Some authors 
found that age can influence clinical symptoms and 
radiographic manifestations, with less cavitation 
frequency in very advanced age or very young 
groups. Conversely, diabetes mellitus is associated 
with higher odds of having cavities (6).
The aforementioned risk factors, along with preg-
nancy and breastfeeding, also impact on treatment. 
Although standard treatment regimens are used, 
close patient follow-ups should be performed and 
each case individually assessed (3). In patients 
with comorbidities and other conditions, such as 
HIV and smoking, a higher percentage of TB recur-
rence has been reported (7,8). In Istanbul, Turkey, 
the presence of alcoholism and smoking, old age, 
low weight and SSM positivity, was associated 
with male gender (9). Other authors reported an 
association between addiction and gender (10-12).
A study conducted in a Buenos Aires city hospital 
in Argentina between 1997 and 2010 determined 
that the most frequent TB comorbidities and other 
conditions were smoking (14%); HIV (6.5%); 
asthma (5.6%) and alcoholism (4.8%) (13). Another 
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study conducted with TB patients over 15 years 
old in Córdoba city, Argentina, reported low weight 
(63%), smoking (61%), alcoholism (23%), illicit 
drugs (22%) and diabetes mellitus (19%), as major 
comorbidities (14).
Eighty percent of the Latin American and Caribbean 
population lives in cities, a proportion that grew 
twofold between 1950 and 2010. The burden of 
TB is higher in urban than in rural areas, both in 
developed and developing countries, this being 
largely attributed to living conditions of the popula-
tion living in peripheral slums (15).
In order to control TB, comprehensive health 
care with an inter-programmatic and cross-sector 
approach is required, coordinating different actors 
and sectors, addressing the main health deter-
minants which promote and aggravate the TB 
endemic, especially in marginal slum populations 
from large cities. This study aimed to determine 
the main comorbidities, associated conditions and 
demographic, clinical and microbiological charac-
teristics of adult TB patients from urban centers in 
Argentina from a gender and age perspective.
Materials and methods
We conducted a cross-sectional study in referral 
hospitals for TB patients from urban areas with more 
than 90,000 inhabitants located in the provinces 
of Buenos Aires, Santa Fe, Santa Cruz and the 
Autonomous City of Buenos Aires. Three provinces 
are in the central region of the country and they 
have a temperate climate and four well-defined sea-
sons; the two cities in Santa Cruz province belong 
to the semi-desert region of Patagonia, where the 
climate is cold, dry, and continuously drafty. The 
cities or municipalities where the study hospitals 
are located were selected for convenience: Caleta 
Olivia and Río Gallegos (Santa Cruz), Avellaneda, 
Florencio Varela, Lanús, Lomas de Zamora, La 
Plata, Merlo, Quilmes, and San Fernando (Buenos 
Aires), Rosario (Santa Fe), and Buenos Aires 
city. We included TB patients of ≥15 years of age 
who were hospitalized or treated by outpatient 
clinics with bacteriologically confirmed pulmonary 
or extrapulmonary TB, as well as patients who, 
although not bacteriologically confirmed, had clin-
ical and radiological characteristics consistent with 
TB and were prescribed TB treatment.
The study period was from August 1st, 2015, to 
August 31st, 2016. Information was obtained from 
patients’ medical records and/or treatment cards. 
A form was specifically designed for the study 
observing enough caution to keep confidentiality 
and not to reveal identities. In the event that by 
error or omission this information was not available 
or not clear enough, an interview was conducted 
with the patients and/or their companions, where 
their consent was requested. Patients whose 
information records could not be completed or 
clarified were excluded. The study was authorized 
by hospital officers and approved by the ethics 
committee within each of them.
Variables in the study included: gender, age, place 
of residence, nationality (based on the birthplace), 
years of residence in Argentina, height and weight, 
TB type (pulmonary or extrapulmonary), type of 
extrapulmonary TB, type of comorbidity or condition 
at the time of diagnosis, pregnancy or puerperium, 
history of previous TB treatment; SSM results, 
culture and chest X-ray at the time of diagnosis; 
HIV serology and treatment results, and need of 
hospitalization during treatment.
Two types of patients were considered: New and 
with a history of treatment. New patients were 
considered as those who had never had TB treat-
ment, or else were treated for TB for less than a 
month; patients with a history of treatment were 
those who were previously treated for TB for more 
than one month and diagnosed again as having 
active TB.
Anyone who smoked at least 100 cigarettes in his 
life and smoked some days or every day at the time 
was considered a smoker.
For the calculation of the body mass index (BMI), 
weight and height were measured at the beginning 
of treatment.
The World Health Organization (WHO) definition of 
alcoholism was adopted: daily ingestion of alcohol 
in excess of 50 g in women and 70 g in men. This 
condition was recorded when this daily alcohol 
consumption was determined by the interview. 
To define drug addiction, we considered those 
substances that patients declared in the interview 
as having used in a compulsive fashion.
Data analysis 
Data analysis was performed using EpiInfo soft-
ware 7.1.5.2. For continuous variables, the mean, 
median and range were determined. To evaluate 
the association between TB patients’ comorbidities 
or characteristics and gender, the presence of 
aids and age groups, we performed a univariate 
analysis; for categorical variables, we used the 
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chi square test or the Fischer exact test. When p 
was less than 0.050, the result was considered 
statistically significant.
Variables with information from more than 300 TB 
cases that resulted in a significance of p<0.100 in 
the univariate analysis were included in a multi-
variate logistic regression model. The strength of 
the association was determined with odds ratios 
(OR) and their 95% confidence intervals (CI). When 
p was less than 0.050, the result was considered 
statistically significant.
Results
We included 378 patients: 163 (43.1%) from 
Buenos Aires province, 120 (31.7%) from Buenos 
Aires city, 49 (13.0%) from Rosario city, Santa 
Fe province, and 46 (12.2%) from Santa Cruz 
province. The mean age was 39.7 and the median 
age 37 (range: 15-89 years). Sixty-five percent of 
TB patients were between 15 and 45 years and the 
highest frequency (36.4%) was registered in the 
15 to 30 year group. Fifty-eight percent (58.2%) 
of TB patients were male; the male/female ratio 
was 1.34 in new patients and relapses, and 2.27 in 
those with a history of treatment.
Among the 327 patients who had the SSM result, 
the culture result of 216 was known, with 139/216 
SSM (+) having positive culture. Only 1/140 patients 
with positive SSM resulted in a negative culture. 
None of the patients in the study was diagnosed 
by molecular methods.
The characteristics and comorbidities of patients 
by gender are shown in table 1. Those showing 
a statistically significant association with male 
gender were: extrapulmonary TB (including mixed: 
pulmonary and extrapulmonary TB), hospitalization, 
smoking, drug addiction, and alcoholism, with the 
following proportions of 37.0, 31.8, 31.5, 20.5 and 
15.1%, respectively, in men. Using a multivariate 
analysis, alcoholism (OR=2.89; 95%CI: 1.01-
8.21; p=0.047) and extrapulmonary TB (OR=2.94; 
95%CI: 1.64 - 5.26; p=0.000) were confirmed as 
statistically significant.
Of the 42 patients with information on the type of 
drug they used, 71.4% used more than one type, 
the most frequent combination being marijuana 
and cocaine.
The BMI mean was 21.6 and the median, 21.2 
(range: 13.1-38.3). Of 206 TB patients, 24.3% were 
underweight (BMI<18.5), 14.6% were overweight 
(BMI: 25-29.99) and 5.3% were obese (BMI≥30). 
Overweight or obese patients had a higher pro-
portion of diabetes mellitus (OR=10.96; 95%CI: 
4.60 -26.12; p=0.000).
Other comorbidities with a frequency higher than 
2% were: COPD (2.9%), rheumatic disease (2.9%), 
hypertension (2.6%), immunosuppressive treatment 
(2.6%), renal disease (2.4%), and cancer (2.1%).
There were three pregnant patients and one 
puerpera, accounting for 0.8% and 0.3% of total 
cases, respectively.
Information on the presence or absence of multi-
drug resistance was obtained for 150 patients and 
four (2.7%) were multiresistant. Of 155 patients 
from whom monoresistance information was col-
lected, eight (5.2%) were resistant to isoniazid and 
six (3.9%) to rifampicin.
Out of 376 TB patients 85 (22.6%) had AIDS. A 
statistically significant association was observed 
between the presence of AIDS and drug use 
(p=0.000), need for hospitalization (p=0.000), 
extrapulmonary TB (p=0.002), extrapulmonary 
TB in localizations other than pleural (p=0.001), 
non-pathological radiology (p=0.001), cavitation 
absence (p=0.001), and negative SSM (p=0.000) 
(table 2). The main forms of extrapulmonary TB 
were miliary, meningeal, and lymph node TB. 
Using multivariate analysis in relation to presence 
of AIDS, drug use (OR: 3.45 (1.04-11.41); p: 0.042), 
hospitalization (OR=4.70; 95%CI: 2.03-10.87; 
p=0.000), non-pathological radiology (OR=11.11; 
95%CI: 1.49-100.00; p=0.020) and SSM (-)  (OR= 
10; 95%CI: 4-25; p=0.000) were confirmed as 
statistically significant.
Of 25 HIV-infected patients whose CD4 T-lympho-
cyte counts were known, 22 had counts below 200 
cells/mm3.
On the basis of the median age of TB patients, the 
population was divided into two groups: <40 years 
and ≥40 years. A statistically significant association 
was observed between those <40 years and drug 
addiction (p= 0.015) and low weight (p=0.004) (table 
3). Patients ≥40 years of age showed a statistically 
significant association with the presence of 
diabetes mellitus (p=0.000), alcoholism (p=0.010) 
and COPD presence (p=0.027). Using multivariate 
analysis, an association was confirmed between 
TB patients <40 and drug addiction (OR=2.71; 
95%CI: 1.34-5.49; p=0.042), and between those 
>40 and alcoholism (OR=3.45; 95%CI: 1.54-7.69; 
p=0.002), and diabetes mellitus (OR=4.35; 95%CI: 
2.08-9.09; p=0.000).
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Discussion
Identification of the best strategies for prevention 
and control of coexisting diseases is vital for 
progress towards the fulfillment of the Sustainable 
Development and the End TB Strategy Goals. This 
can only be possible with a thorough knowledge 
of how these diseases develop. Although social 
determinants of health are the chief factors behind 
the ongoing TB pandemic, there are other known 
risk factors of Mycobacterium tuberculosis infec-
tion and progression to active disease (16). This 
study aimed at determining the main comorbid-
ities and conditions, and demographic, clinical, and 
Table 1. Comorbidities, other associated conditions and demographic, clinical, and microbiological characteristics of tuberculosis 
adult patients in urban conglomerates of Argentina, according to gender. August 2015-August 2016
Characteristic Total1 Male Female                 OR2             p3
Argentinian4
Yes
No
Total
284 (79.8)
72 (20.2)
356 (100.0)
162 (77.9)
46 (22.1) 208 
(100.0)
122 (82.4)
26 (17.6) 
148 (100.0)
0.75 (0.44-1.28) 0.293
Hospitalized5
Yes
No
Total
84 (26.3)
235 (73.7)
319 (100.0)
57 (31.8)
122(68.2)
179 (100.0)
27 (19.3)
113 (80.7)
140 (100.0)
1.95 (1.16-3.30) 0.012
Low weight
Yes
No
Total
49 (23.9)
156 (76.1)
205 (100.0)
27 (23.7)
87 (76.3)
114 (100.0)
22 (24.2)
69 (75.8)
91 (100.0)
0.97 (0.51-1.86) 0.935
New case
Yes
No
Total
318 (86.4)
50 (13.6)
368 (100.0)
180 (83.7)
35 (16.3)
215 (100.0)
138 (90.2)
15 (9.8)
153 (100.0)
0.56 (0.29-1.06) 0.074
Extrapulmonary6 TB7
Yes
No
Total
109 (29.3)
263 (70.7)
372 (100.0)
80 (37.0)
136 (63.0)
216 (100.0)
29 (18.6)
127 (81.4)
156 (100.0)
2.58 (1.58-4.20) 0.000
Cavitation
Yes
No
Total
133 (51.0)
128 (49.0)
261 (100.0)
72 (50.3)
71 (49.7)
143 (100.0)
61 (51.7)
57 (48.3)
118 (100.0)
0.95 (0.58-1.54) 0.829
SSM (+)8
Yes
No
Total
210 (64.2)
117 (35.8)
327 (100.0)
114 (60.6)
74 (39.4)
188 (100.0)
96 (69.1)
43 (30.9)
139 (100.0)
0.70 (0.44-1.11) 0.128
AIDS
Yes
No
Total
85 (22.6)
291 (77.4)
376 (100.0)
57 (26.0)
162 (74.0)
219 (100.0)
28 (17.8)
129 (82.2)
157 (100.0)
1.62 (0.97-2.69) 0.061
Diabetes
Yes
No
Total
47 (12.5)
329 (87.5)
376 (100.0)
31 (14.2)
188 (85.8)
219 (100.0)
16 (10.2)
141 (89.8)
157 (100.0)
1.45 (0.76-2.76) 0.252
Alcoholism
Yes
No
Total
39 (10.4)
337 (89.6)
376 (100.0)
33 (15.1)
124 (84.9)
157 (100.0)
6 (3.8)
213 (96.2)
219 (100.0)
4.46 (1.82-10.94) 0.000
Drug addiction
Yes
No
Total
55 (14.6)
321 (85.4)
376 (100.0)
45 (20.5)
174 (79.5)
219 (100.0)
10 (6.4)
147 (93.6)
157 (100.0)
3.80 (1.85-7.81) 0.000
Smoking
Yes
No
Total
101 (26.9)
275 (73.1)
376 (100.0)
69 (31.5)
150 (68.5)
219 (100.0)
32 (20.4)
125 (79.6)
157 (100.0)
1.80 (1.11-2.91) 0.016
1 Values expressed as n (%); 2 OR: Odds ratio; 3 p: p value; 4 Argentinian: born in Argentina; 5 Hospitalized: patient who required hospitalization during 
treatment; 6 Extrapulmonary TB: includes exclusive extrapulmonary locations and mixed locations (pulmonary + extrapulmonary); 7 TB: tuberculosis; 
8 SSM (+): positive sputum smear microscopy 
185
Biomédica 2018;38:180-8 Tuberculosis and comorbidities in Argentina
bacteriological characteristics of adult TB patients 
in urban centers in Argentina, approaching them 
from a gender and age perspective. 
The highest frequency of ages in the 15-to-30 year 
group coincides with the information published by 
Argentina’s NTP, where the highest new case and 
relapse notification rates occur in groups of 20 to 24, 
25 to 29 and 30 to 34 years (2). The prevalence of 
new cases and relapses in young groups could be 
attributed to a TB sustained transmission in the com-
munity. In keeping with reports from the Argentinean 
NTP, there is a higher proportion of males, both in 
new and relapsed cases and in non-new ones (2).
WHO indicates that active or passive exposure to 
tobacco smoke is significantly associated with both 
TB infection and disease. Being an active smoker 
is also significantly associated with recurrent TB 
and mortality by TB (17).
Hassmiller, in a review, concludes that smoking is 
associated with risks of becoming infected with M. 
tuberculosis, developing TB, presenting with TB 
more severe forms, and dying from it, observing in 
many cases a strong dose-response relationship, 
in terms of smoking volume as well as duration 
(18). In this study, smoking appears as the most 
frequent condition among TB patients. 
Table 2. Comorbidities, other associated conditions and demographic, clinical, and microbiological characteristics of tuberculosis 
adult patients in urban conglomerates of Argentina, according to their AIDS status. August, 2015-August, 2016
Characteristic Total1 With AIDS Without AIDS          OR2         p3
<40years
Yes
No
Total
202 (54.0)
172 (46.0)
374 (100.0)
40 (47.1) 
45 (52.9)
85 (100.0)
162 (56.1)
127 (43.9)
289 (100.0)
0.70 (0.43-1.13) 0.144
Drug addiction
Yes
No
Total
55 (14,8)
321 (85.2)
376 (100.0)
29 (33.7)
57 (66.3)
86 (100.0)
26 (9.2)
264 (90.8)
290 (100.0)
4.99 (2.75-9.07) 0.000
Alcoholism
Yes
No
Total
40 (10.6)
336 (89.4)
376 (100.0)
14 (16.3)
72 (83.7)
86 (100.0)
26 (8.9)
264 (91.1)
290 (100.0)
1.99 (0.99-4.00) 0.051
Hospitalized4
Yes
No
Total
85 (26.5)
236 (73.5)
321 (100.0)
35 (56.4)
27 (43.6)
62 (100.0)
50 (19.3)
209 (80.7)
259 (100.0)
5.42 (3.00-9.77) 0.000
Smoking
No 
Yes
Total
276 (73.4)
100 (26.6)
376 (100.0)
225 (77.3)
66 (22.7)
291 (100.0)
51 (60.0)
34 (40.0)
85 (100.0)
2.40 (1.41-4.00) 0.001
Pathologic RX5
No
Yes
Total
12 (3.9)
299 (96.1)
311 (100.0)
7 (10.6)
59 (89.4)
66 (100.0)
5 (2.0)
240 (98.0)
245 (100.0)
5.55 (1.75-20) 0.001
Cavitation
No
Yes
Total
128 (48.9)134 
(51.1)
262 (100.0)
29 (74.4)
10 (25.6)
39 (100.0)
99 (44.4)
124 (55.6)
223 (100.0)
3.70 (1.69-7.69) 0.001
Extrapulmonary6 TB7
Yes
No
Total
109 (29.1)
265 (70.9)
374 (100.0)
36 (42.4)
49 (57.6)
85 (100.0)
73 (25.3)
216 (74.7)
289 (100.0)
2.17 (1.31-3.60) 0.002
Pleural8 TB7
No
Yes
Total
50 (47.2)
56 (52.8) 
106 (100.0)
27 (81.8)
6 (18.2)
35 (100.0)
23 (31.5)
50 (68.5)
73 (100.0)
10.00 (3.57-25.00) 0.000
SSM (+)9
No
Yes
Total
117 (35.8)210 
(64.2)
327 (100.0)
49 (71.0) 
20 (29.0)
69 (100.0)
68 (26.4)
190 (73.6)
258 (100.0)
6.67 (3.85-12.5) 0.000
1 Values expressed as n (%); 2 OR: Odds ratio; 3 p: p value; 4 Hospitalized: patient who required hospitalization during treatment; 5 Rx: radiology; 
6 Extrapulmonary TB: includes exclusive extrapulmonary locations and mixed locations (pulmonary + extrapulmonary); 7 TB: tuberculosis; 8 Pleural TB: 
includes exclusive pleural locations and mixed locations (pleural + pulmonary); 9 SSM (+): positive sputum smear microscopy
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Kirenga,et al., in Uganda, reported 26.3% of 
patients with a history of smoking; Cruz-Hervert, 
et al., in Vera Cruz (México) determined 25% of 
smokers, finding a statistically significant associa-
tion between this addiction and ages <45 (5,19). 
These values  are similar to the 26.9% found in 
Argentina, where there is no apparent association 
with age, but there is with regard to male gender. 
It is in this gender that, as documented, tobacco 
addiction prevails among the overall population 
(12,20,21). These findings are relevant because a 
positive association between smoking and a lack of 
adherence to anti-tuberculosis treatment (22) has 
been highlighted.
The specific rate of HIV cases per 100,000 inha-
bitants in Argentina was 21.6 in 2011 (last year 
with complete information), totaling 18.8/100,000 
inhabitants in 2013, but with incomplete notification 
(23). AIDS is another comorbidity associated with 
TB in this study’s urban centers, occurring in 22.6% 
of TB patients. While associations between AIDS, 
male gender and age of ≥40 years were observed, 
they were not statistically significant. Association 
with male gender could be related to an increase in 
the male/female ratio of HIV diagnoses in all regions 
in Argentina, and the connection with ages of ≥40 
years could reside in the fact that the median age 
of HIV diagnosis is 33 (23). Patients with AIDS are 
hospitalized almost five times more often than those 
without AIDS; they also have fewer pathological 
X-rays, less SSM positivity, and CD4+ T cell counts 
below 200 cells/mm3. Similar findings were also 
reported in a retrospective study conducted in 
Perú in 2016 (24). Only 18.2% of patients with TB/
HIV coinfection and extrapulmonary TB presented 
pleural forms; in those patients without co-infection, 
pleural TB accounted for 68.5% of cases. 
An increased risk of TB infection, as well as that 
of TB disease among drug users, has been 
highlighted even before the emergence of HIV. 
Outbreaks of TB, both sensitive and drug-resistant, 
have also been described among drug users (25). 
According to previous studies, transmission of TB 
among cocaine users could be due to the presence 
of multiple risk factors in the places where they 
gather for consumption. In these patients the odds 
Table 3. Comorbidities, other associated conditions, and demographic and clinical characteristics of tuberculosis adult patients in 
urban conglomerates of Argentina according age. August 2015-August 2016
Characteristic Total1 <40 years ≥40 years            OR2 p3
Drug addiction
Yes
No
Total
55 (14.7)
319 (85.3)
374 (100.0)
38 (18.8)
164 (81.2)
202 (100.0)
17 (9.9)
155 (90.1)
172 (100.0)
2.11 (1.14-3.9) 0.015
Alcoholism
Yes
No
Total
38 (10.2)
336 (89.8)
374 (100.0)
13 (6.4)
189 (93.6)
202 (100.0)
25 (14.5)
147 (85.5)
172 (100.0)
0.40 (0.20-0.82) 0.010
Hospitalized4
Yes
No
Total
84 (26.2)
236 (73.7)
320 (100.0)
47 (25.8)
135 (74.2)
182 (100.0)
37 (26.8)
101 (73.2)
138 (100.0)
0.95 (0.57-1.57) 0.843
Smoking
Yes
No
Total
99 (26.5)
275 (73.5)
374 (100.0)
50 (24.7)
152 (75.3)
202 (100.0)
49 (28.5)
123 (71.5)
172 (100.0)
0.83 (0.52-1.31) 0.415
Low weight
Yes
No
Total
50 (24.4)
155 (75.6)
205 (100.0)
37 (31.9)
79 (68.1)
116 (100.0)
13 (14.6)
76 (85.4)
89 (100.0)
2.74 (1.35-5.55) 0.004
Diabetes
Yes
No
Total
47 (12.6)
327 (87.4)
374 (100.0)
11 (5.5)
191 (94.5)
202 (100.0) 
36 (20.9)
136 (79.1)
172 (100.0)
0.22 (0.11-0.44) 0.000
COPD5
Yes
No
Total
11 (2.9)
362 (97.1)
373 (100.0)
2 (1.0)
200 (99.0)
202 (100.0)
9 (5.3)
162 (94.7)
171 (100.0)
0.18 (0.04-0.84) 0.027
1 Values expressed as n (%); 2 OR: Odds ratio; 3 p: p value; 4 Hospitalized: patient who required hospitalization during treatment; 5 COPD: Chronic 
Obstructive Pulmonary Disease
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of treatment default are higher, remaining infec-
tious for extended periods after diagnosis and 
developing drug resistant TB (26). In this study, 
drug use was one of the most common conditions 
(14.6%), and it was related to male gender, the 
presence of AIDS, and ages under 40 among TB 
patients. On this basis, strategies can be designed 
which adapt to these circumstances, thus reducing 
its negative outcomes.
Low weight is another common feature among TB 
patients, occurring in 24.3% of them and rising to 
31.9% in patients <40 years of age. Other authors 
have found a mean BMI of 21.1, very similar to that 
in Argentina, which did not decrease significantly 
in the presence of comorbidities (4). In Córdoba, 
Argentina, 63% of patients had a BMI<21.63, very 
similar to that of this study where the median was 
21.22 (14). Zachariah, et al. found that patients 
with a BMI<17 had a higher risk of dying than 
those with a BMI≥18.5 (27); in that case, 12.2% of 
patients in Argentina would be at increased risk of 
dying because of their low weight. Another study 
found that overweight was not associated with the 
risk of dying during TB treatment; however, low 
weight was (28). In this respect, in urban centers 
from Argentina, 24.3% of patients being treated for 
TB had a higher risk of dying. 
In a systematic review of TB research, diabetes 
mellitus appears to increase about threefold the 
risk of developing TB disease (29). Patients with TB 
and diabetes mellitus have also a higher baseline 
bacterial burden, longer bacteriological conversion 
time during treatment, higher risk of having multi-
drug resistance, treatment failure, and recurrence 
and death, compared to patients without diabetes 
mellitus (30,31). In Argentina 4 out of 10 adult peo-
ple were overweight and 2 out of 10 were obese; 
1 out of 10 (9.8% of the total population aged ≥18) 
had diabetes mellitus, according to data from the 
Third National Risk Factor Survey conducted in 
2013 (32). This prevalence of diabetes mellitus is 
consistent with the 12.5% by TB patients in this 
study. The association between diabetes mellitus 
and overweight or obesity and age of ≥40 suggests 
it is necessary to carry out a comprehensive TB 
and diabetes mellitus approach, focusing this issue 
on patients >40 who are overweight or obese.
One study limitation was illegibility or incomplete 
information in medical records available in health 
services. So was staff turnover in hospitals, which 
meant that the person to enter the patient was not 
aware of the information to be collected at the time 
or the importance of requesting HIV testing.
Another limitation is that at the time the study 
analysis was conducted, many patients were still 
under treatment, so it was not possible to know 
their outcome.
This study not only helps recognize the character-
istics and comorbidities of TB patients influencing 
TB development and evolution, for their approach 
within clinics, it also characterizes them by age and 
gender, thus facilitating inter-sector approaches to 
cover social and community aspects. This type of 
study and its approach strategy should be imple-
mented by NTPs to help reduce the scourge of TB.
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